AKAM vs AZN
As of Sep 20, 2026, Akamai Technologies (AKAM) scores 3.2/10 and Astrazeneca (AZN) 5.0/10 on AlphaStocks' five-model composite, so AZN scores higher. AKAM trades 4% below its model fair value; AZN trades 14% below its model fair value.
AKAM
AKAMAI TECHNOLOGIES INC
3.2
Weak
$104.53
AZN
ASTRAZENECA PLC
5.0
Consider Buy
$166.29
AKAM vs AZN: Which is the Better Investment?
AKAMAI TECHNOLOGIES INC (AKAM) scores 3.2/10 while ASTRAZENECA PLC (AZN) scores 5.0/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Consider Buy. On a P/E basis, ASTRAZENECA PLC trades at 25.4x, making it the more attractively priced of the two. ASTRAZENECA PLC trades further below its estimated fair value.
This comparison is algorithmically generated and is not financial advice.
| Metric | AKAM | AZN |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 3.2/10 | 5.0/10▲ |
| Rating | Weak | Consider Buy▲ |
| Price | $104.53 | $166.29 |
| P/E Ratio | 34.0 | 25.4▲ |
| ROE | 9.3% | 21.9%▲ |
| Market Cap | $16B | $260B |
| Fair Value | $109.18 | $192.63 |
| Dividend Yield | — | 1.9% |
| Sector Rank | #185 of 205 | #111 of 168▲ |
| Model Verdicts | ||
| Piotroski | Attractive | Strong▲ |
| Buffett | Neutral | Strong▲ |
| Graham | Caution | Caution |
| Lynch | Caution | Neutral▲ |
| Greenblatt | Caution | Neutral▲ |
Related comparisons
AKAM vs AZN: Which Stock Scores Higher?
AKAMAI TECHNOLOGIES INC (AKAM) is in the Information Technology sector; ASTRAZENECA PLC (AZN) is in Health Care. AZN currently leads with a composite score of 5.0/10 (Consider Buy) compared to AKAM's 3.2/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer